IR-Med Statistics
IR-Med (IRME) Stock Statistics & Valuation Metrics
Total Valuation
IR-Med has a market cap or net worth of $204.49K. The enterprise value is $727.67B.
- Market Cap
- $204.49K
- Enterprise Value
- $727.67B
Share Statistics
IR-Med has 97,377,690 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 97,377,690
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
IR-Med’s return on equity (ROE) is 6.46 and return on invested capital (ROIC) is 1416.79%.
- Return on Equity (ROE)
- 6.46
- Return on Assets (ROA)
- -7.57
- Return on Invested Capital (ROIC)
- 1416.79%
- Return on Capital Employed (ROCE)
- 6.60
- Revenue Per Employee
- 0
- Profits Per Employee
- -633.00K
- Employee Count
- 3
- Asset Turnover
- 0.00
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of IR-Med is -0.08. IR-Med’s PEG ratio is -0.00.
- PE Ratio
- -0.08
- PS Ratio
- 0.00
- PB Ratio
- -0.50
- Price to FCF
- -0.15
- Price to Operating Cash Flow
- -0.11
- PEG Ratio
- -0.00
Income Statement
In the last 12 months, IR-Med had revenue of 0 and earned -1.90M in profits. Earnings per share was -0.03.
- Revenue
- 0
- Gross Profit
- -21.00K
- Operating Income
- -1.94M
- Pretax Income
- -1.90M
- Net Income
- -1.90M
- EBITDA
- -1.88M
- Earnings Per Share (EPS)
- -0.03
Cash Flow
In the last 12 months, operating cash flow was -837.00K and capital expenditures 0, giving a free cash flow of -837.00K billion.
- Operating Cash Flow
- -837.00K
- Free Cash Flow
- -837.00K
- Free Cash Flow per Share
- -0.02
Dividends & Yields
IR-Med pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -677.77%
- Earnings Yield
- -1283.14%
Stock Price Statistics
- Beta
- -1.38
- 52-Week Price Change
- -13.33%
- 50-Day Moving Average
- 0.04
- 200-Day Moving Average
- 0.04
- Relative Strength Index (RSI)
- 51.72
- Average Volume (3m)
- ―
Financial Position
IR-Med as a current ratio of 0.38, with Debt / Equity ratio of -53.40%
- Current Ratio
- 0.38
- Quick Ratio
- 0.38
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- -0.01
- Interest Coverage Ratio
- -647.00
Taxes
In the past 12 months, IR-Med has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
IR-Med EV to EBITDA ratio is -0.12, with an EV/FCF ratio of -0.17.
- EV to Sales
- 0.00
- EV to EBITDA
- -0.12
- EV to Free Cash Flow
- -0.17
- EV to Operating Cash Flow
- -0.17
Balance Sheet
IR-Med has $63.00K in cash and marketable securities with $250.00K in debt, giving a net cash position of -$187.00K billion.
- Cash & Marketable Securities
- $63.00K
- Total Debt
- $250.00K
- Net Cash
- -$187.00K
- Net Cash Per Share
- $0.00
- Tangible Book Value Per Share
- -$0.01
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
- Gross Margin
- 0.00%
- Operating Margin
- 0.00%
- Pretax Margin
- 0.00%
- Net Profit Margin
- 0.00%
- EBITDA Margin
- 0.00%
- EBIT Margin
- 0.00%
Analyst Forecast
The average price target for IR-Med is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- 0
- Revenue Growth Forecast
- ―
- EPS Growth Forecast
- ―
